Yes, I'm thinking that also, especially here in the US since the companies involved in the production of stem cells are small and interestingly the parent company of Performance Cell Manufacturing is VetStem Biopharma who is in the same field as Sorrentos Ark Animal Health. Do you think the UK or Brazil could be a possibility for that or is the pressure politically and intuitionally to hard to break through?
News 
Market Data 
Discover 
AI
